Cubist Systematic Strategies’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-92,281
| Closed | -$1.71M | – | 4257 |
|
|
2023
Q3 | $1.71M | Buy |
+92,281
| New | +$1.04M | 0.01% | 1478 |
|
|
2023
Q2 | – | Sell |
-107,344
| Closed | -$1.44M | – | 4533 |
|
|
2023
Q1 | $1.44M | Sell |
107,344
-118,507
| -52% | -$2.05M | 0.01% | 1906 |
|
|
2022
Q4 | $2.79M | Sell |
225,851
-108,317
| -32% | -$1.53M | 0.02% | 1540 |
|
|
2022
Q3 | $4.66M | Buy |
334,168
+261,412
| +359% | +$4.21M | 0.03% | 1139 |
|
|
2022
Q2 | $1M | Sell |
72,756
-130,495
| -64% | -$2.09M | 0.01% | 2482 |
|
|
2022
Q1 | $3.31M | Buy |
203,251
+89,247
| +78% | +$1.4M | 0.03% | 1067 |
|
|
2021
Q4 | $1.86M | Buy |
114,004
+18,780
| +20% | +$317K | 0.02% | 1436 |
|
|
2021
Q3 | $1.41M | Buy |
95,224
+12,631
| +15% | +$202K | 0.02% | 1263 |
|
|
2021
Q2 | $1.65M | Sell |
82,593
-36,114
| -30% | -$716K | 0.02% | 1214 |
|
|
2021
Q1 | $2.74M | Sell |
118,707
-27,448
| -19% | -$765K | 0.04% | 818 |
|
|
2020
Q4 | $3.61M | Buy |
146,155
+108,600
| +289% | +$3.6M | 0.05% | 606 |
|
|
2020
Q3 | $1.56M | Buy |
37,555
+25,173
| +203% | +$1.16M | 0.02% | 1062 |
|
|
2020
Q2 | $593K | Sell |
12,382
-20,687
| -63% | -$1.6M | 0.01% | 1501 |
|
|
2020
Q1 | $2.08M | Sell |
33,069
-24,842
| -43% | -$2.23M | 0.06% | 457 |
|
|
2019
Q4 | $7.18M | Buy |
57,911
+31,266
| +117% | +$2.8M | 0.13% | 178 |
|
|
2019
Q3 | $1.77M | Buy |
26,645
+17,265
| +184% | +$1.16M | 0.04% | 679 |
|
|
2019
Q2 | $746K | Buy |
+9,380
| New | +$840K | 0.01% | 1207 |
|
|
2019
Q1 | – | Sell |
-500
| Closed | -$50K | – | 2465 |
|
|
2018
Q4 | $50K | Buy |
+500
| New | +$51.8K | ﹤0.01% | 1867 |
|
|
2018
Q2 | – | Sell |
-286
| Closed | -$18K | – | 2117 |
|
|
2018
Q1 | $18K | Sell |
286
-3,414
| -92% | -$206K | ﹤0.01% | 1753 |
|
|
2017
Q4 | $216K | Sell |
3,700
-3,017
| -45% | -$190K | 0.01% | 1479 |
|
|
2017
Q3 | $390K | Buy |
6,717
+2,734
| +69% | +$294K | 0.02% | 986 |
|
|
2017
Q2 | $482K | Buy |
3,983
+3,283
| +469% | +$380K | 0.03% | 770 |
|
|
2017
Q1 | $79K | Sell |
700
-2,952
| -81% | -$345K | 0.01% | 1422 |
|
|
2016
Q4 | $397K | Buy |
+3,652
| New | +$435K | 0.03% | 794 |
|
|
2016
Q2 | – | Sell |
-117
| Closed | -$15K | – | 1927 |
|
|
2016
Q1 | $15K | Sell |
117
-5,398
| -98% | -$637K | ﹤0.01% | 1544 |
|
|
2015
Q4 | $824K | Buy |
+5,515
| New | +$934K | 0.05% | 567 |
|
|
2015
Q2 | – | Sell |
-1,493
| Closed | -$421K | – | 2095 |
|
|
2015
Q1 | $421K | Buy |
1,493
+1,293
| +647% | +$280K | 0.02% | 1034 |
|
|
2014
Q4 | $31K | Sell |
200
-9,900
| -98% | -$1.83M | ﹤0.01% | 1803 |
|
|
2014
Q3 | $2.39M | Sell |
10,100
-3,109
| -24% | -$793K | 0.15% | 173 |
|
|
2014
Q2 | $3.13M | Buy |
+13,209
| New | +$3.48M | 0.19% | 123 |
|